SAN JOSE, Calif., June 26, 2017 -- POET Technologies Inc. (the “Company” or “POET”) (OTCQX:POETF) (TSX Venture:PTK), a developer of opto-electronic fabrication processes for the semiconductor industry, has published a new slide presentation in the Investor Relations section of its website, which management intends to use as part of investor meetings this week to help raise awareness of the Company. Additionally, management plans to review these slides as part of the agenda at the upcoming Annual General Meeting scheduled for July 13, 2017, which will be webcast.
A copy of the slide presentation can be found on the Company’s website at http://www.poet-technologies.com/presentations-and-events.html
About POET Technologies Inc.
POET (Planar Opto-Electronic Technology) and its subsidiaries are developers of opto-electronic and photonic fabrication processes, devices and products. The company's vision is to enable the integration of photonics and electronics through both monolithic and hybrid approaches to design and packaging. Integration is fundamental to increasing functional scaling and lowering the cost of current photonic solutions that drive applications in data communications, consumer products and industrial sensing. Leveraging both Gallium Arsenide (GaAs) and Indium Phosphide (InP) technology platforms, POET believes that its advanced processes for active photonic devices and innovative passive components provide a unique and differentiated combination that will enable substantial improvements in component cost, size and performance over current photonic solutions. More information may be obtained at www.poet-technologies.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
120 Eglinton Avenue, East, Suite 1107, Toronto, ON, M4P 1E2- Tel: 416-368-9411 - Fax: 416-322-5075
Shareholder Contact: Shelton Group Brett L. Perry Leanne K. Sievers E: [email protected]


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Amazon Explores AI Content Marketplace With Media Publishers
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Samsung Electronics Shares Jump on HBM4 Mass Production Report
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Anta Sports Expands Global Footprint With Strategic Puma Stake
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



